Presidential Document2023-24488
National Alzheimer's Disease Awareness Month, 2023
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 3, 2023
Signed
October 31, 2023
Issuing agencies
Executive Office of the President
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 212 (Friday, November 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Presidential Documents]
[Pages 75455-75456]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-24488]
Presidential Documents
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 /
Presidential Documents
[[Page 75455]]
Proclamation 10662 of October 31, 2023
National Alzheimer's Disease Awareness Month,
2023
By the President of the United States of America
A Proclamation
Over six million Americans live with Alzheimer's
disease, a form of dementia that deprives people of
their precious memories, thoughts, and identity. During
National Alzheimer's Disease Awareness Month, we honor
the extraordinary courage, strength, and resilience of
people facing this devastating disease. We recognize
the support of families and caregivers who stand by
their loved one's side and help them age with dignity.
We resolve to continue advancing scientific research
and treatment options to ensure a brighter future for
all Americans facing Alzheimer's.
Today, Alzheimer's remains a leading cause of death in
older adults. It exacts an emotional, physical, and
financial toll on the entire family of those who are
diagnosed--especially for African Americans and
Latinos, who are more likely to develop dementias than
any other races or ethnicities, and for individuals
with Down syndrome, who are at higher risk for
Alzheimer's. My Administration has taken numerous
actions to help treat and prevent this terrible
disease. We worked with the Congress to secure $2.5
billion in bipartisan funding for the Advanced Research
Projects Agency for Health (ARPA-H). This agency is
developing critical breakthroughs in preventing,
diagnosing, and treating Alzheimer's and other deadly
diseases and pioneering partnerships to get those
breakthroughs out to clinics and patients.
Earlier this year, the Food and Drug Administration
granted the first-ever approval for a prescription drug
that can alter the course of Alzheimer's in some
people, rather than simply treat symptoms--a sign of
hope to so many patients and families affected by this
disease. In addition, I was proud to sign an Executive
Order on Increasing Access to High-Quality Care and
Supporting Caregivers. As a result, the Centers for
Medicare and Medicaid Services (CMS) announced a
groundbreaking model that will offer a comprehensive
package for care management and coordination for people
living with Alzheimer's and related dementias,
caregiver support and education, and respite services.
Meanwhile, CMS continues to offer services that help
people access cognitive care assessments, ensuring that
those with Alzheimer's receive the care they need. In
addition, the Centers for Disease Control and
Prevention is creating a uniform national public health
infrastructure focused on increasing early detection
and diagnosis of Alzheimer's disease and related
dementias, reducing dementia risk, preventing avoidable
hospitalizations, and supporting caregivers of those
living with dementia.
This November, let us honor the memory of those we have
tragically lost to Alzheimer's. Let us recognize the
millions of Americans who are living with the impact of
this condition every day and all the incredible
caregivers, doctors, researchers, and advocates
supporting them. Let us come together as a Nation;
carry forward a spirit of hope; and recommit to doing
everything we can to prevent, treat, and eliminate this
disease.
NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of
the United States of America, by virtue of the
authority vested in me by the Constitution and the laws
of the United States, do hereby proclaim November 2023
as National Alzheimer's Disease Awareness Month. I call
on the people
[[Page 75456]]
of the United States of America to honor and support
those living with Alzheimer's and the many people who
continue extraordinary and tireless efforts to combat
this disorder. I encourage all Americans to visit
<a href="http://www.Alzheimers.gov">www.Alzheimers.gov</a> for evidence-based resources and
information.
IN WITNESS WHEREOF, I have hereunto set my hand this
thirty-first day of October, in the year of our Lord
two thousand twenty-three, and of the Independence of
the United States of America the two hundred and forty-
eighth.
<GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
(Presidential Sig.)
[FR Doc. 2023-24488
Filed 11-2-23; 8:45 am]
Billing code 3395-F4-P
</pre></body>
</html>Indexed from Federal Register on November 3, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.